Identification | More | [Name]
(R)-(-)-3-Pyrrolidinol hydrochloride | [CAS]
104706-47-0 | [Synonyms]
3-FURANAMINE, TETRAHYDRO-, (R)-, HYDROCHLORIDE 3-PYRROLIDINOL, HYDROCHLORIDE, (3R)- 3-PYRROLIDINOL, HYDROCHLORIDE, (3S) 3R-HYDROXYPYROLIDINE HCL (R)-3-AMINOTETRAHYDROFURAN HYDROCHLORIDE (R)-3-HYDROXYPYRROLIDINE HCL (R)-(-)-3-HYDROXYPYRROLIDINE HYDROCHLORIDE (R)-3-HYDROXYPYRROLIDINE HYDROCHLORIDE (R)-(-)-3-PYRROLIDINOL HYDROCHLORIDE (R)-(+)-3-PYRROLIDINOL HYDROCHLORIDE (R)-3-PYRROLIDINOL HYDROCHLORIDE (R)-PYRROLIDINE-3-OL HYDROCHLORIDE (R)-TETRAHYDROFURAN-3-AMINE HYDROCHLORIDE (S)-3-HYDROXY PYRROLIDINE HCL (S)-3-HYDROXYPYRROLIDINE HYDROCHLORIDE (S)-(-)-3-PYRROLIDINOL HYDROCHLORIDE (S)-3-PYRROLIDINOL HYDROCHLORIDE (S)-PYRROLIDIN-3-OL HCL (S)-PYRROLIDINE-3-OL HYDROCHLORIDE TIMTEC-BB SBB004272 | [EINECS(EC#)]
600-598-9 | [Molecular Formula]
C4H10ClNO | [MDL Number]
MFCD00272298 | [Molecular Weight]
123.58 | [MOL File]
104706-47-0.mol |
Chemical Properties | Back Directory | [Melting point ]
104-107 °C(lit.)
| [alpha ]
-7.6°(20/D, c=3,5, CH3OH) | [refractive index ]
-7.8 ° (C=3.5, MeOH) | [storage temp. ]
Inert atmosphere,Room Temperature | [solubility ]
Soluble in DMSO. | [form ]
Solid | [color ]
Pale Brown | [Optical Rotation]
[α]20/D 7.6°, c = 3.5 in methanol | [Detection Methods]
T | [BRN ]
4450078 | [InChI]
InChI=1/C4H9NO.ClH/c6-4-1-2-5-3-4;/h4-6H,1-3H2;1H/t4-;/s3 | [InChIKey]
QPMSJEFZULFYTB-PGMHMLKASA-N | [SMILES]
[C@H]1(O)CNCC1.Cl |&1:0,r| | [CAS DataBase Reference]
104706-47-0(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36:Wear suitable protective clothing . | [WGK Germany ]
3
| [F ]
3-10 | [HS Code ]
29339900 |
Hazard Information | Back Directory | [Chemical Properties]
Llight brown crystalline | [Uses]
(R)-(-)-3-Pyrrolidinol hydrochloride is a chiral hydroxy derivative of pyrrlodine used in the preparation of chiral niologically active compounds such as muscarinic receptor antagonists and antimicrobial agents.
| [Synthesis]
Example 1: Preparation of (R)-3-hydroxypyrrolidine hydrochloride (Formula VII): cyclohexanol (80 liters) was added to the reactor and heated to 155°C. Water was removed by azeotropic distillation until the water content in the solvent did not exceed 0.2% (w/w). The solvent was then cooled to 45 °C and (2S,4R)-4-hydroxy-2-pyrrolidinecarboxylic acid (15 kg) was added and stirred for 10 min. Methyl isobutyl ketone (4.275 liters) was added to the reaction mixture, reheated to 154°C and maintained at this temperature for 5 hours of reaction. The reaction process was monitored by thin layer chromatography. Upon completion of the reaction, the reaction mixture was cooled to 0 °C under nitrogen protection and the pH was adjusted to 1.0-2.0 with ether-HCl (41 l). pH adjustment was completed, the temperature was raised to 25 °C and maintained for 2-3 h. The reaction mixture was then heated to 154 °C and maintained at this temperature for 5 h. The solid product was filtered and the reaction mixture was then heated to 154 °C. The solid product was collected by filtration and washed successively with ethyl acetate (30 liters in two portions) and isopropanol (15 liters). The wet solid was dried by suction for 1-2 hours and then dried under reduced pressure at 55°C for 5 hours to give 10.7 kg (R)-3-hydroxypyrrolidine hydrochloride in 76% yield and 98.5% HPLC purity. | [Purification Methods]
The (±)-isomer is purified by repeated distillation ( b 102-104o/12mm, 108-110o/18mm), and the (±)-picrate crystallises from EtOH with m 140-141o. The R(+)-enantiomer has b 70o/0.6mm and [] D +5.6o (c 3.63, MeOH). Its hydrochloride has a negative rotation and its dimethiodide has m 230o and [] 24 -8.02o. [Suyama & Kanno Yakugaku Zasshi (J Pharm Soc Japan) 85 531 1965, Uno et al. J Heterocycl Chem 24 1025 1987, Flanagan & Joullie Heterocycles 26 2247 1987, Beilstein 21 III/IV 44.] | [References]
[1] Patent: WO2008/100651, 2008, A2. Location in patent: Page/Page column 15; 32-33 [2] Patent: WO2015/110886, 2015, A1. Location in patent: Page/Page column 14 [3] Patent: WO2004/56767, 2004, A1. Location in patent: Page 14 [4] Journal of Medicinal Chemistry, 1992, vol. 35, # 10, p. 1764 - 1773 |
|
|